Publication | Open Access

Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks

T-cell SuppressionBone Marrow FailureMedicineStem Cell MobilizationImmunologyHematologyBlood CellAutoimmunityCell BiologyHuman Bone MarrowImmunotherapyCytokine-chemokine NetworksCell TransplantationMyelopoiesis